The latest news, releases and announcements

Hermes Medical Solutions (HMS), a global leader in molecular imaging and dosimetry software solutions, proudly announces the latest updates within Hermia, including new CE marked functionalities*, designed to advance precision and efficiency in nuclear medicine imaging and dosimetry.

Hermes Medical Solutions is proud to announce its participation in the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium’s groundbreaking Precision Dosimetry Imaging Biomarker (PDIB) project. This ambitious international initiative seeks to transform radiopharmaceutical therapy (RPT) through improved dosimetry, leading to more effective and personalized cancer treatments.

In a testament to its global impact, the top hospitals recognized in Newsweek's World's Best Hospitals 2025 rankings have integrated Hermia, the all-in-one molecular imaging software suite from Hermes Medical Solutions, into their clinical practices. From leading institutions in the United States and to premier hospitals in Europe and beyond, Hermia has become an essential tool in delivering precise diagnostics and optimized patient care.

Hermes Medical Solutions (HMS), a leader in molecular imaging software development will demonstrate its true vendor-neutral character through partnerships at this year’s RSNA to provide customers of Canon Medical Systems, Siemens Healthineers and Spectrum Dynamics Medical with access to the Hermia software.

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions receives 510(k) FDA Clearance for its Hybrid Viewer 7.0. The product has previously been CE-marked and holds a medical device license from Health Canada.

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions is excited to showcase all new and upcoming product updates to the All-in-One Molecular Imaging Software Suite Hermia at EANM 2024.